White Paper: Pharmacovigilance in HCP social media listening

A guide for Drug Safety professionals, and anybody involved in scoping or approving social media listening projects with healthcare professionals.

Fill out your details below to receive your copy of this Whitepaper for simple tools to inform constructive conversations with your colleagues in market research, or digital marketing, or brand teams, about their social media listening.

Related Resources

14.07.2025 | Article

How Novartis’ scientific momentum is translating at the digital front line of care

Evidence-based insights on Novartis' digital influence.

By Bernard Groen and Jessica Fernandes

08.07.2025 | Article

Top 50 Pharma Tracker: governmental decisions and ASCO 2025 drove HCP conversation about pharma since April

Governmental decisions and ASCO 2025 drove HCP conversation about pharma

02.07.2025 | Webinars

The Advanced Guide to DOLs

This webinar is useful for pharmaceutical leaders who understand the concept of a DOL.

01.07.2025 | Article

How HCPs are shaping lung cancer treatment online

We identified and analysed over 100,000 that specifically focused on lung cancer.

By Daniel Ghinn

24.06.2025 | Article

What oncologists really talked about at ASCO 2025 — and why it matters

Behind the podium presentations and poster halls, there’s another layer of insight unfolding

By Jon Gunne

18.06.2025 | Article

What is a Digital Opinion Leader?

What (or who) exactly is a Digital Opinion Leader?